Myeloid cell-targeted therapies for solid tumours
Myeloid cells are the most abundant immune components of the tumour microenvironment,
where they have a variety of functions, ranging from immunosuppressive to …
where they have a variety of functions, ranging from immunosuppressive to …
Intratumoral microbiota: roles in cancer initiation, development and therapeutic efficacy
L Yang, A Li, Y Wang, Y Zhang - Signal Transduction and Targeted …, 2023 - nature.com
Microorganisms, including bacteria, viruses, fungi, and other eukaryotes, play critical roles in
human health. An altered microbiome can be associated with complex diseases …
human health. An altered microbiome can be associated with complex diseases …
The microbiome-derived metabolite TMAO drives immune activation and boosts responses to immune checkpoint blockade in pancreatic cancer
The composition of the gut microbiome can control innate and adaptive immunity and has
emerged as a key regulator of tumor growth, especially in the context of immune checkpoint …
emerged as a key regulator of tumor growth, especially in the context of immune checkpoint …
STING-induced regulatory B cells compromise NK function in cancer immunity
S Li, B Mirlekar, BM Johnson, WJ Brickey, JA Wrobel… - Nature, 2022 - nature.com
An immunosuppressive tumour microenvironment is a major obstacle in the control of
pancreatic and other solid cancers,–. Agonists of the stimulator of interferon g enes (STING) …
pancreatic and other solid cancers,–. Agonists of the stimulator of interferon g enes (STING) …
Turning up the heat on non-immunoreactive tumours: opportunities for clinical development
MO de Olza, BN Rodrigo, S Zimmermann… - The Lancet …, 2020 - thelancet.com
Notable advances have been achieved in the treatment of cancer since the advent of
immunotherapy, and immune checkpoint inhibitors have shown clinical benefit across a …
immunotherapy, and immune checkpoint inhibitors have shown clinical benefit across a …
Engineered PLGA microparticles for long-term, pulsatile release of STING agonist for cancer immunotherapy
Activation of the stimulator of interferon gene (STING) pathway within the tumor
microenvironment has been shown to generate a strong antitumor response. Although local …
microenvironment has been shown to generate a strong antitumor response. Although local …
The cGAS-STING pathway: a promising immunotherapy target
L Ou, A Zhang, Y Cheng, Y Chen - Frontiers in immunology, 2021 - frontiersin.org
With the continuous development of immunotherapy, researchers have paid more attention
to the specific immune regulatory mechanisms of various immune responses in different …
to the specific immune regulatory mechanisms of various immune responses in different …
Novel strategies for cancer immunotherapy: counter-immunoediting therapy
S Liu, Q Sun, X Ren - Journal of Hematology & Oncology, 2023 - Springer
The advent of immunotherapy has made an indelible mark on the field of cancer therapy,
especially the application of immune checkpoint inhibitors in clinical practice. Although …
especially the application of immune checkpoint inhibitors in clinical practice. Although …
STING: a master regulator in the cancer-immunity cycle
Y Zhu, X An, X Zhang, Y Qiao, T Zheng, X Li - Molecular cancer, 2019 - Springer
The aberrant appearance of DNA in the cytoplasm triggers the activation of cGAS-cGAMP-
STING signaling and induces the production of type I interferons, which play critical roles in …
STING signaling and induces the production of type I interferons, which play critical roles in …
POLQ inhibition elicits an immune response in homologous recombination–deficient pancreatic adenocarcinoma via cGAS/STING signaling
G Oh, A Wang, L Wang, J Li, G Werba… - The Journal of …, 2023 - Am Soc Clin Investig
Pancreatic ductal adenocarcinoma (PDAC) is a highly lethal malignancy that harbors
mutations in homologous recombination–repair (HR-repair) proteins in 20%–25% of cases …
mutations in homologous recombination–repair (HR-repair) proteins in 20%–25% of cases …